Echo-enhanced doppler sonography of focal nodular hyperplasia of the liver

Journal of Ultrasound in Medicine

Volumn 18, Issue 7, 1999, Pages 445-451

  Uggowitzer, Martin M ^a,b   Kugler, Christian ^a   Mischinger, Hans Joerg ^a   Gröll, Reinhard ^a   Ruppert Kohlmayr, Andrea ^a   Preidler, Klaus Werner ^a   Quehenberger, Franz ^c  

^a UNIVERSITY OF GRAZ   (Austria)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c NONE

Author keywords

Echo enhancing agents; Focal nodular hyperplasia; Liver

Indexed keywords

CONTRAST MEDIA; DOPPLER EFFECT; MEDICAL IMAGING; PATIENT MONITORING; SIGNAL TO NOISE RATIO;

ECHO-ENHANCED DOPPLER SONOGRAPHY; ECHO-ENHANCING AGENTS; FOCAL NODULAR HYPERPLASIA; LIVER;

ULTRASONIC IMAGING;

SHU 508;

ADULT; ANGIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC VALUE; DOPPLER FLOWMETRY; FEMALE; HEPATIC ARTERY; HUMAN; INTERMETHOD COMPARISON; INTRAVENOUS DRUG ADMINISTRATION; LIVER; LIVER BLOOD FLOW; LIVER CIRCULATION; LIVER STRUCTURE; NODULAR HYPERPLASIA; SIGNAL NOISE RATIO; TREATMENT OUTCOME; TUMOR VOLUME;

EID: 0033046074     PISSN: 02784297     EISSN: None     Source Type: Journal    
DOI: 10.7863/jum.1999.18.7.445     Document Type: Article

References (28)

1. Wanless IR, Mawdsley C, Adams R: On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology 5:1194, 1985
2. Whelan TJ, Baugh JH, Chandor S: Focal nodular hyperplasia of the liver. Ann Surg 177:150, 1973
3. Knowles DM, Wolff M: Focal nodular hyperplasia of the liver: A clinicopathologic study and review of the literature. Hum Pathol 7:533, 1976
4. Shamsi K, De Schepper A, Degryse H, et al: Focal nodular hyperplasia of the liver: CT and sonographic spectrum. Abdom Imaging 18:32, 1993
5. Rummeny E, Weissleder R, Sironi S, et al: Central scars in primary liver tumors: MR features, specificity, and pathologic correlation. Radiology 171:323, 1989
6. Mathieu D, Zafrani ES, Anglade MC, et al: Association of focal nodular hyperplasia and hepatic hemangioma. Gastroenterology 97:154, 1989
7. Schwarz KQ, Becher H, Schimpfky C, et al: Doppler enhancement with SHU 508A in multiple vascular regions. Radiology 193:195, 1994
8. Fujimoto M, Moriyasu F, Nishikawa Y, et al: Color Doppler sonography of hepatic tumors with a galactose-based contrast agent: Correlation with angiographic findings. AJR 163:1099, 1994
9. Rosenkranz K, Zendel W, Langer R, et al: Contrast-enhanced transcranial Doppler US with a new transpulmonary echo contrast agent based on saccharide microparticles. Radiology 187:439, 1993
10. Schlief R, Schürmann R, Balzer T, et al: Saccharide based contrast agent. In Nanda NC, Schlief R (Eds): Advances in Echo Imaging Using Contrast Enhancement. Boston, Kluwer Academic Publishers, 1993, p 71
11. Uggowitzer M, Kugler C, Machan L, et al: Power Doppler imaging and evaluation of the resistive index in focal nodular hyperplasia of the liver. Abdom Imaging 22:268, 1997
12. Couinaud C: Le foie: Etudes anatomiques et chirugicales. Paris, Masson, 1957, p 9
13. Mahfouz AE, Hamm B, Taupitz M, et al: Hypervascular liver lesions: Differentiation of focal nodular hyperplasia malignant tumors with the dynamic gadolinium-enhanced MR imaging. Radiology 186:133, 1993
14. Mathieu D, Bruneton JN, Drouillard J, et al: Hepatic adenoma and focal nodular hyperplasia: Dynamic CT study. Radiology 160:53, 1986
15. Yamashita Y, Hatanaka Y, Yamamoto H, et al: Differential diagnosis of focal liver lesions: Role of spin-echo and contrast-enhanced dynamic MR imaging. Radiology 193:59, 1994
16. Takayasu K, Muramatsu Y, Moriyama N, et al: Focal nodular hyperplasia of the liver: Arterial angio-CT and microangiopathy. J Comput Assist Tomogr 16:212, 1992
17. Stocker JT, Ishak KG: Focal nodular hyperplasia of the liver: A study of 21 pediatric cases. Cancer 48:336, 1981
18. Kudo M, Tomita S, Tochio H, et al: Hepatic focal nodular hyperplasia: Specific findings at dynamic contrast-enhanced US with carbon dioxide microbubbles. Radiology 179:377, 1991
19. Caiati C, Schlief R, Aragona PL, et al: Enhanced Doppler signal intensity in coronary artery after intravenous injection of lung crossing echocontrast agent (SHU 508A). J Am Coll Cardiol 19:323, 1992
20. Bogdahn U, Becker G, Schlief R, et al: Contrast-enhanced transcranial color-coded real-time sonography: Results of phase two study. Stroke 24:676, 1993
21. Schroeder K, Voeller H, Agrawaj R, et al: Improved border delineation in suboptimal stress echocardiography by the new left heart contrast agent SHU 508A. J Am Coll Cardiol 19:175, 1992
22. Forsberg F, Liu JB, Burns PN, et al: Artifacts in ultrasonic contrast agent studies. J Ultrasound Med 13:357, 1994
23. Casarella WJ, Knowles DM, Wolff M, et al: Focal nodular hyperplasia and liver cell adenoma: Radiologic and pathologic differentiation. AJR 131:393, 1978
24. Golfieri R, Giampalma E, Berordi R, et al: Early-stage focal nodular hyperplasia: US/CT/MR features correlated with histology. Eur Radiol 4:65, 1994
25. Ishak KG: Benign tumors and pseudotumors of the liver. Appl Pathol 6:82, 1988
26. Lalonde L, vanBeers B, Trigaux J-P, et al: Focal nodular hyperplasia in association with spontaneous intrahepatic portosystemic venous shunt. Gastrointest Radiol 17:154, 1992
27. Welch TJ, Sheedy PF, Johnson CM, et al: Focal nodular hyperplasia and hepatic adenoma: Comparison of angiography; CT, US and scintigraphy. Radiology 156:593, 1985
28. Tanaka S, Kitamura T, Yoshioko F, et al: Effectiveness of galactose-based intravenous contrast medium on color Doppler sonography of deeply located hepatocellular carcinoma. Ultrasound Med Biol 21:157, 1995